PMDA drug package insert
アラグリオ原末分包1.5g
PMDA Prescription drug · SBIファーマ株式会社 · package insert Jul 21, 2026
Key facts
| Brand names | アラグリオ原末分包1.5g |
|---|---|
| Nonproprietary names | アミノレブリン酸塩酸塩 |
| Companies | 製造販売元／SBIファーマ株式会社, 販売元／日本化薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 光線力学診断用剤 |
| Therapeutic category codes | 87729 |
| YJ codes | 7290007A1020 |
| Approval numbers | 30800AMX00094000 |
| Package insert edition | 第2版 |
| Package insert date | Jul 21, 2026 |
| PMDA document key | 171155_7290007A1020_1 |
| PMDA company code | 171155 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: